Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
During an ongoing Ebola virus outbreak, infection before onset of protective immunity from vaccination is a possible scenario. Here the authors show in non-human primates that vaccination shortly before treatment with a monoclonal antibody does not negatively affect effectiveness of the antibody the...
Guardado en:
Autores principales: | Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Joan B. Geisbert, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Kevin Melody, Karla A. Fenton, Heinz Feldmann, Armand Sprecher, Larry Zeitlin, Thomas W. Geisbert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f42ceaff066b4e269cda66de8d4403a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge
por: Teresa E. Sorvillo, et al.
Publicado: (2021) -
<italic toggle="yes">Bundibugyo ebolavirus</italic> Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Courtney Woolsey, et al.
Publicado: (2021) -
Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection
por: Andrea R. Menicucci, et al.
Publicado: (2017) -
Combination therapy protects macaques against advanced Marburg virus disease
por: Robert W. Cross, et al.
Publicado: (2021) -
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
por: Thomas W. Geisbert, et al.
Publicado: (2021)